A carregar...
A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses
Monoclonal antibodies (MAbs) that interfere with checkpoint molecules are being investigated for the treatment of infectious diseases and cancer, with the aim of enhancing the function of an impaired immune system. Avelumab (MSB0010718C) is a fully human IgG1 MAb targeting programmed death-ligand 1...
Na minha lista:
| Publicado no: | Clin Transl Immunology |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910121/ https://ncbi.nlm.nih.gov/pubmed/27350882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cti.2016.27 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|